List view / Grid view

Biologics

 

Quality assessment of biologics: higher order structure analysis using NMR

27 July 2018 | By Bruker

Two webinar sessions will be available on 27 September at 9AM (BST) and 4PM (BST). Select your preferred time slot during registration.  The webinar will describe how 2D NMR can offer protein biochemists unprecedented analytical precision. By assigning just one spectrum, users can obtain a unique fingerprint of a protein at…

DNA microarrays and multidrug resistant bacteria

1 March 2018 | By

In parallel with the use of a wide range of antibiotics for treating infectious diseases worldwide, antimicrobial resistance has significantly increased. For this reason, the application of an advanced pangenomic technique like DNA microarray can be an effective, rapid, accurate, sensitive, specific and flexible methodology for detecting, identifying and determining…

Non-clinical dose formulation considerations

15 December 2017 | By

Designing appropriate non-clinical safety studies requires thoughtful, and sometimes experimental, consideration of the delivery methodology for the therapeutic. The choice of formulation affects drug release and absorption and has a direct impact on the pharmacokinetic profile and associated response of the model system. The formulation should be compatible with the…

Send this to a friend